Literature DB >> 18544915

Functional analysis of transcriptional activity of cytosine and adenine (CA) repeats polymorphism in the estrogen receptor beta gene.

Kanako Ugai, Kazuhiro Nishimura, Katsumi Fukino, Tomonori Nakamura, Koichi Ueno.   

Abstract

Cytosine and adenine (CA) repeats polymorphism (D14S1026) iterating "cytosine and adenine" nucleotide motifs is one of the genomic microsatellites in intron 5 of the estrogen receptor beta (ER beta) gene (14q22-24). Relations between CA repeats polymorphism and several diseases have been shown. Although the relation between number of CA repeats and gene transcription has been actively studied using several genes, results have remained contradictory until this time. In this study, we examined the functional effects of CA repeats polymorphism on transcriptional activity based on our knowledge of the ER beta gene. After preparing four types of reporter gene constructs containing 15, 18, 24 or 27 CA repeats, luciferase reporter gene assays were performed. Relative luciferase activities of these constructs were not significantly different from that of the no inserted vector and variation of CA repeats did not affect these activities. Our results indicate that CA repeats polymorphism might not only affect transcriptional activity but also other processes of gene expressions. Further studies are needed to clarify the specific functions of CA repeats polymorphism in the ER beta gene.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18544915     DOI: 10.2131/jts.33.237

Source DB:  PubMed          Journal:  J Toxicol Sci        ISSN: 0388-1350            Impact factor:   2.196


  5 in total

1.  Gender-specific genomic profiling in metastatic colorectal cancer patients treated with 5-fluorouracil and oxaliplatin.

Authors:  Michael A Gordon; Wu Zhang; Dongyun Yang; Syma Iqbal; Anthony El-Khouiery; Fumio Nagashima; Georg Lurje; Melissa Labonte; Peter Wilson; Andy Sherrod; Robert D Ladner; Heinz-Josef Lenz
Journal:  Pharmacogenomics       Date:  2011-01       Impact factor: 2.533

2.  Gender-related survival differences associated with polymorphic variants of estrogen receptor-β (ERβ) in patients with metastatic colon cancer.

Authors:  O A Press; W Zhang; M A Gordon; D Yang; C A Haiman; M Azuma; S Iqbal; H-J Lenz
Journal:  Pharmacogenomics J       Date:  2010-06-15       Impact factor: 3.550

3.  Association between estrogen receptor-β dinucleotide repeat polymorphism and incidence of femoral fracture.

Authors:  Naoko Honma; Seijiro Mori; Heying Zhou; Shinobu Ikeda; Makiko Naka Mieno; Noriko Tanaka; Kaiyo Takubo; Tomio Arai; Motoji Sawabe; Masaaki Muramatsu; Hideki Ito
Journal:  J Bone Miner Metab       Date:  2012-09-05       Impact factor: 2.626

4.  A GA microsatellite in the Fli1 promoter modulates gene expression and is associated with systemic lupus erythematosus patients without nephritis.

Authors:  Erin E Morris; May Y Amria; Emily Kistner-Griffin; John L Svenson; Diane L Kamen; Gary S Gilkeson; Tamara K Nowling
Journal:  Arthritis Res Ther       Date:  2010-11-18       Impact factor: 5.156

5.  Repeat polymorphisms in ESR2 and AR and colorectal cancer risk and prognosis: results from a German population-based case-control study.

Authors:  Anja Rudolph; Hong Shi; Asta Försti; Michael Hoffmeister; Juan Sainz; Lina Jansen; Kari Hemminki; Hermann Brenner; Jenny Chang-Claude
Journal:  BMC Cancer       Date:  2014-11-07       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.